SOUTH SAN FRANCISCO, CA--(Marketwire - October 16, 2007) - Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that two posters covering preclinical data from research on the mitotic kinesin centromere-associated protein E (CENP-E) and an inhibitor of CENP-E, GSK-923295, will be presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held from October 22-26, 2007 at the Moscone West Convention Center, San Francisco, California.
